Abstract
Pathologists play critical roles in the clinical management and research of renal cell carcinoma (RCC). Careful assessment by pathologists of a cancer-harboring kidney specimen not only renders an accurate histological diagnosis and classification, but also provides information important for prognosis and therapeutic decisions. In addition, redundant tumor tissues not required for diagnosis could be procured for clinical trials, experimental therapies, and research. This chapter briefly describes how the RCC specimens are processed in pathology laboratories and how clinicians can facilitate such a process. In addition, important pathological and cytogenetic features of different subtypes of RCC will also be discussed.
Original language | English (US) |
---|---|
Title of host publication | Renal Cell Carcinoma |
Subtitle of host publication | Molecular Targets and Clinical Applications |
Publisher | Humana Press |
Pages | 35-48 |
Number of pages | 14 |
ISBN (Print) | 9781588297372 |
DOIs | |
State | Published - 2009 |
Keywords
- Cytogenetics
- Pathology
- Prognosis
- Renal cell carcinoma
- Renal neoplasm
ASJC Scopus subject areas
- General Medicine